Up a level |
Exarchou, Klaire, Hu, Haiyi, Stephens, Nathan A, Moore, Andrew R, Kelly, Mark, Lamarca, Angela, Mansoor, Wasat, Hubner, Richard, McNamara, Mairead G, Smart, Howard et al (show 3 more authors)
(2022)
Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter.
ENDOCRINE, 78 (1).
pp. 186-196.
Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Barriuso, Jorge, Lamarca, Angela, Manoharan, Prakash, Westwood, Thomas, Jaffa, Matthew, Fenwick, Stephen W, Nuttall, Christina, Lalloo, Fiona, Prachalias, Andreas et al (show 12 more authors)
(2021)
The Impact of <SUP>68</SUP>Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours.
FRONTIERS IN ENDOCRINOLOGY, 12.
654975-.
Edeline, Julien, Lamarca, Angela, McNamara, Mairead G, Jacobs, Timothy, Hubner, Richard A, Palmer, Dan ORCID: 0000-0002-7147-5703, Koerkamp, Bas Groot, Johnson, Philip ORCID: 0000-0003-1404-0209, Guiu, Boris and Valle, Juan W
(2021)
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis.
CANCER TREATMENT REVIEWS, 99.
102258-.
Gray, Simon ORCID: 0000-0001-8396-3328, Lamarca, Angela, McNamara, Mairéad G, Edeline, Julien, Piper‐Hanley, Karen, Valle, Juan W and Hubner, Richard A
(2023)
Prognostic and predictive factors for locoregional and systemic therapies in hepatocellular carcinoma.
Liver Cancer International, 4 (1).
pp. 13-27.
Lamarca, Angela, Pritchard, D Mark ORCID: 0000-0001-7971-3561, Westwood, Thomas, Papaxoinis, Georgios, Nonaka, Daisuke, Vinjamuri, Sobhan, Valle, Juan W, Manoharan, Prakash and Mansoor, Wasat
(2018)
<SUP>68</SUP>Gallium DOTANOC-PET Imaging in Lung Carcinoids: Impact on Patients' Management.
NEUROENDOCRINOLOGY, 106 (2).
pp. 128-138.
Lamarca, Angela, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari et al (show 11 more authors)
(2021)
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
LANCET ONCOLOGY, 22 (5).
pp. 690-701.
Gray, Simon ORCID: 0000-0001-8396-3328, Lamarca, Angela, Edeline, Julien, Klumpen, Heinz-Josef, Hubner, Richard A, McNamara, Mairead G and Valle, Juan W
(2022)
Targeted Therapies for Perihilar Cholangiocarcinoma.
CANCERS, 14 (7).
1789-.
Gray, Simon ORCID: 0000-0001-8396-3328, Letissier, Octave, d'Abrigeon, Constance, Shah, Dinakshi, Wardell, Stephen, Faluyi, Olusola, Lamarca, Angela, Hubner, Richard A, Edeline, Julien, Valle, Juan W et al (show 1 more authors)
(2023)
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes.
CANCERS, 15 (11).
3047-.